MOSHKEVICH SOLOMON (PRESIDENT, CLINICALDIAGNOSTICS) sold 2.2% of their position (3K shares) of NATERA, INC. on the open market
Open‑market sale worth $818.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 7/7/2026ACC: 0002010019-26-000016
Officer· PRESIDENT, CLINICALDIAGNOSTICS
Since Feb 2026
-3K
Net shares
Net seller
$818.7K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−100.00
Price / share
$267.19
Trade value
$26.72K
% of position
0.1%
7/1/2026
137.64K→137.54K
Common Stock
Direct
Shares
−2.60K
Price / share
$272.99
Trade value
$709.77K
% of position
1.9%
7/1/2026
137.54K→134.94K
Common Stock
Direct
Shares
−300.00
Price / share
$274.06
Trade value
$82.22K
% of position
0.2%
7/1/2026
134.94K→134.64K
Total
Net shares
−3K
Net value
-$818.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | S · Sale | −100.00 | $267.19 | $26.72K | 0.1% | 137.64K | 137.54K |
| Common Stock Direct | 7/1/2026 | S · Sale | −2.60K | $272.99 | $709.77K | 1.9% | 137.54K | 134.94K |
| Common Stock Direct | 7/1/2026 | S · Sale | −300.00 | $274.06 | $82.22K | 0.2% | 134.94K | 134.64K |
| Total | −3K | -$818.71K | ||||||
Derivative Transactions0
No derivative transactions reported